Viewing Study NCT06082635


Ignite Creation Date: 2025-12-24 @ 10:29 PM
Ignite Modification Date: 2025-12-29 @ 9:08 PM
Study NCT ID: NCT06082635
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-18
First Post: 2023-10-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor: Shenzhen TargetRx, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module